Generic Eliquis Prices (apixaban)

What is Apixaban?

Apixaban (Brand name: Eliquis) is prescribed for the prevention of strokes or blood clots in people who have atrial fibrillation. It also treats and prevents blood clots in the legs and/or lungs. Apixaban works by stopping the action of a natural substance in the body that helps form blood clots. 

In general, the names and strengths of drugs can vary globally due to differing marketing strategies. Any variations need to be approved by your prescriber. In apixaban’s case, the name differs across markets. PharmacyChecker is not aware of strength differences across countries. 

Apixaban is marketed under the brand name Eliquis in much of the world by Pfizer and Bristol-Myers Squibb. 

There are many generic alternatives of Eliquis approved in Canada now. They carry the same active ingredient as Eliquis, apixaban. In Canada, apixaban is approved by Health Canada to be manufactured and marketed by the following companies:

• Teva Canada Limited marketed under the name Teva-Apixaban 

• Pro Doc Limitee marketed under the name Pro-Apixaban 

• Laboratoire Riva Inc marketed under the name Riva Apixaban 

• Sandoz Canada Incorporated marketed under the name Sandoz Apixaban SDZ 

• Sun Pharma Canada Inc marketed under the name Taro-Apixaban

• Marcan Pharmaceuticals Inc marketed under the name Mar-Apixaban 

• Mint Pharmaceuticals Inc marketed under the name Mint-Apixaban 

• Natco Pharma (Canada) Inc marketed under the name Nat-Apixaban 

• Nora Pharma Inc marketed under the name NRA-Apixaban 

• Auro Pharma Inc marketed under the name Auro-Apixaban 

• Biomed pharma marketed under the name Bio-apixaban 

• Bristol Myers Squibb marketed under the name Eliquis 

• JAMP Pharma Corporation marketed under the name JAMP apixaban 

• Mantra Pharma Inc marketed under the name M-apixaban 

• Accord Healthcare Inc marketed under the name ACH-apixaban

• Angita Pharma Inc. marketed under the name AG-apixaban 

• Sivem Pharmaceuticals ULC marketed under the name Apixaban 

• Sanis Health Inc approved under the name Apixaban 

• Apotex Inc marketed under the name APO-apixaban 

Apixaban is manufactured and marketed under the name Apigat in India by Natco Pharma. In 2019, the Delhi High Court dismissed attempts by Bristol-Myers Squibb to protect its patented apixaban against Natco’s Apigat.

The U.S. FDA has approved the following companies to market a generic version: Indoco, Hetero Labs, Sun Pharma, and Accord, but approval does not equal availability. A generic alternative for Eliquis will most likely be launched in the United States in April 2028. Brand Eliquis is among the first ten medications proposed for Medicare price negotiations in the United States; negotiated pricing would go into effect in 2026.

Apixaban Savings & Safety Information